Live feed
Filing
SC 13G
SC 13G0000929638-24-000374·Corbus Pharmaceuticals Holdings, Inc.
Schedule 13G ownership disclosure
Corbus Pharmaceuticals Holdings Inc
Security class unavailable · CUSIP: 21833P301
Event date: 2024-01-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-24-000374
- Form type
- SC 13G
- Filer
- Corbus Pharmaceuticals Holdings, Inc.
- CIK
- CIK 1595097
- Filed
- Feb 05, 2024
- Reporting period
- Jan 26, 2024
- Description
- Schedule 13G beneficial ownership